title: Letter: new treatments for hepatitis C have implications for quality of life in people who inject drugs.
authors.affiliation: Faculty of Health Sciences, NDRI, Curtin University, Fitzroy, Vic., Australia. peter.higgs@curtin.edu.au.|Centre for Population Health, The Burnet Institute, Melbourne, Vic., Australia. peter.higgs@curtin.edu.au.
authors.forename: P
authors.initials: P
authors.lastname: Higgs
authors.affiliation: Centre for Population Health, The Burnet Institute, Melbourne, Vic., Australia.
authors.forename: C
authors.initials: C
authors.lastname: Wright
authors.affiliation: Centre for Population Health, The Burnet Institute, Melbourne, Vic., Australia.
authors.forename: M
authors.initials: M
authors.lastname: Hellard
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons